Posted in | News

Phenom World Demonstrate their Gunshot Residue (GSR) Analysis System at the Forensics Europe Expo

Phenom World are demonstrating the world's first desktop SEM that can run automated GSR analysis at Forensics Europe Expo in London on the 19th of 20th of April, 2016.

Gunshot Residue (GSR) analysis plays an important role in the determination if a firearm has been used in a crime. Established GSR analysis techniques are based on the use of a scanning electron microscope (SEM), which is used to scan the sample and find suspect GSR particle. The Phenom GSR is based on the Phenom XL desktop SEM. Both software and hardware are fully integrated to enhace user-friendliness, reliability and analysis speed

The key features of their system are;

  • Fast and reliable results on plano reference samples
  • GSR software fully conforms to the ASTM standards
  • Capability to handle wide range of forensic applications

The live product demonstrations can be observed at their booth (G-47)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Phenom-World BV. (2019, February 08). Phenom World Demonstrate their Gunshot Residue (GSR) Analysis System at the Forensics Europe Expo. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=45481.

  • MLA

    Thermo Fisher Scientific Phenom-World BV. "Phenom World Demonstrate their Gunshot Residue (GSR) Analysis System at the Forensics Europe Expo". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=45481>.

  • Chicago

    Thermo Fisher Scientific Phenom-World BV. "Phenom World Demonstrate their Gunshot Residue (GSR) Analysis System at the Forensics Europe Expo". AZoM. https://www.azom.com/news.aspx?newsID=45481. (accessed November 23, 2024).

  • Harvard

    Thermo Fisher Scientific Phenom-World BV. 2019. Phenom World Demonstrate their Gunshot Residue (GSR) Analysis System at the Forensics Europe Expo. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=45481.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.